These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 18807045

  • 1. Anasarca as the presenting manifestation of parvovirus B19 associated juvenile dermatomyositis.
    Chandrakasan S, Singh S, Ratho RK, Kumar S, Mishra B.
    Rheumatol Int; 2009 Mar; 29(5):565-7. PubMed ID: 18807045
    [Abstract] [Full Text] [Related]

  • 2. Juvenile dermatomyositis in a child infected with human parvovirus B19.
    Lewkonia RM, Horne D, Dawood MR.
    Clin Infect Dis; 1995 Aug; 21(2):430-2. PubMed ID: 8562756
    [Abstract] [Full Text] [Related]

  • 3. Anasarca: not a nephrotic syndrome but dermatomyositis.
    Zedan M, El-Ayouty M, Abdel-Hady H, Shouman B, El-Assmy M, Fouda A.
    Eur J Pediatr; 2008 Jul; 167(7):831-4. PubMed ID: 18414893
    [Abstract] [Full Text] [Related]

  • 4. Dermatomyositis associated with the presence of parvovirus B19 DNA in muscle.
    Chevrel G, Calvet A, Belin V, Miossec P.
    Rheumatology (Oxford); 2000 Sep; 39(9):1037-9. PubMed ID: 10986312
    [Abstract] [Full Text] [Related]

  • 5. A causal role for parvovirus B19 infection in adult dermatomyositis and other autoimmune syndromes.
    Crowson AN, Magro CM, Dawood MR.
    J Cutan Pathol; 2000 Nov; 27(10):505-15. PubMed ID: 11100810
    [Abstract] [Full Text] [Related]

  • 6. Anasarca as the presenting symptom of juvenile dermatomyositis: a case series.
    Schildt EE, De Ranieri D.
    Pediatr Rheumatol Online J; 2021 Aug 13; 19(1):120. PubMed ID: 34389019
    [Abstract] [Full Text] [Related]

  • 7. Juvenile dermatomyositis presenting with anasarca.
    Saygi S, Alehan F, Baskin E, Bayrakci US, Ulu EM, Ozbek N.
    J Child Neurol; 2008 Nov 13; 23(11):1353-6. PubMed ID: 18984850
    [Abstract] [Full Text] [Related]

  • 8. Acute hepatitis and myositis associated with Erythema infectiosum by Parvovirus B19 in an adolescent.
    Koliou M, Karaoli E, Soteriades ES, Pavlides S, Bashiardes S, Christodoulou C.
    BMC Pediatr; 2014 Jan 13; 14():6. PubMed ID: 24410941
    [Abstract] [Full Text] [Related]

  • 9. The cutaneous manifestations of human parvovirus B19 infection.
    Magro CM, Dawood MR, Crowson AN.
    Hum Pathol; 2000 Apr 13; 31(4):488-97. PubMed ID: 10821497
    [Abstract] [Full Text] [Related]

  • 10. Generalized petechial eruption induced by parvovirus B19 infection.
    McNeely M, Friedman J, Pope E.
    J Am Acad Dermatol; 2005 May 13; 52(5 Suppl 1):S109-13. PubMed ID: 15858505
    [Abstract] [Full Text] [Related]

  • 11. Parvovirus B19 and onset of juvenile dermatomyositis.
    Mamyrova G, Rider LG, Haagenson L, Wong S, Brown KE.
    JAMA; 2005 Nov 02; 294(17):2170-1. PubMed ID: 16264157
    [No Abstract] [Full Text] [Related]

  • 12. The Role of Human Parvovirus B19 in the Pediatric Patients with Pancytopenia?
    Colak M, Kocak AA, Dinc B, Kaya Z, Kocak U, Yenicesu İ, Bozdayi G.
    Clin Lab; 2019 Dec 01; 65(12):. PubMed ID: 31850715
    [Abstract] [Full Text] [Related]

  • 13. Anasarca as the initial presentation of juvenile polymyositis: an uncommon occurrence.
    Sharma D, Singh S, Suri D, Rawat A, Shava U, Sodhi KS.
    Rheumatol Int; 2012 Aug 01; 32(8):2589-90. PubMed ID: 21805348
    [Abstract] [Full Text] [Related]

  • 14. Nephrotic syndrome associated with human parvovirus B19 infection.
    Ohtomo Y, Kawamura R, Kaneko K, Yamashiro Y, Kiyokawa N, Taguchi T, Mimori K, Fujimoto J.
    Pediatr Nephrol; 2003 Mar 01; 18(3):280-2. PubMed ID: 12644924
    [Abstract] [Full Text] [Related]

  • 15. Increased prevalence of human parvovirus B19 DNA in systemic sclerosis skin.
    Ohtsuka T, Yamazaki S.
    Br J Dermatol; 2004 Jun 01; 150(6):1091-5. PubMed ID: 15214893
    [Abstract] [Full Text] [Related]

  • 16. Immune-mediated inner ear disease and parvovirus B19.
    Cotter CS, Singleton GT, Corman LC.
    Laryngoscope; 1994 Oct 01; 104(10):1235-9. PubMed ID: 7934594
    [Abstract] [Full Text] [Related]

  • 17. Acute cerebellar ataxia with human parvovirus B19 infection.
    Shimizu Y, Ueno T, Komatsu H, Takada H, Nunoue T.
    Arch Dis Child; 1999 Jan 01; 80(1):72-3. PubMed ID: 10325764
    [Abstract] [Full Text] [Related]

  • 18. Human parvovirus B19 specific IgG, IgA, and IgM antibodies and DNA in serum specimens from persons with erythema infectiosum.
    Erdman DD, Usher MJ, Tsou C, Caul EO, Gary GW, Kajigaya S, Young NS, Anderson LJ.
    J Med Virol; 1991 Oct 01; 35(2):110-5. PubMed ID: 1765775
    [Abstract] [Full Text] [Related]

  • 19. Transient erythroblastopenia due to human parvovirus B19 infection: a case report of a boy suffering from purpura.
    Miyata H, Yagi K, Takemura T, Maki S.
    Acta Paediatr Jpn; 1994 Apr 01; 36(2):217-9. PubMed ID: 8203271
    [Abstract] [Full Text] [Related]

  • 20. Limb edema and anasarca associated with severe dermatomyositis: report of four cases.
    Chai Y, Bertorini TE, Li YD, Mitchell C, Guan H.
    Neuromuscul Disord; 2011 Jun 01; 21(6):439-42. PubMed ID: 21482469
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.